Related Experiment Videos
Case reports: continuous corticosteroids for refractory poorly differentiated lymphocytic lymphoma
1Division of Hematology/Oncology, Department of Medicine, Grady Memorial Hospital, Atlanta, Georgia, USA.
The American Journal of the Medical Sciences
|September 1, 1996
Summary
Continuous corticosteroids induced long-term remission in two patients with advanced lymphocytic lymphoma refractory to chemotherapy. This treatment offers an inexpensive palliative option for this incurable cancer.
Area of Science:
- Oncology
- Hematology
- Pharmacology
Background:
- Stage IV poorly differentiated lymphocytic lymphoma is an aggressive cancer.
- Patients often become refractory to standard intensive combination chemotherapy.
- Refractory disease can involve bone marrow replacement and leukemia.